Singapore markets close in 4 hours 37 minutes

Ono Pharmaceutical Co., Ltd. (4528.T)

Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
2,211.00+14.50 (+0.66%)
As of 01:03PM JST. Market open.
Currency in JPY

Valuation measures4

Market cap (intra-day) 1.03T
Enterprise value 835.85B
Trailing P/E 8.24
Forward P/E 13.95
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.10
Price/book (mrq)1.30
Enterprise value/revenue 1.66
Enterprise value/EBITDA 4.59

Trading information

Stock price history

Beta (5Y monthly) 0.17
52-week change 3-15.63%
S&P500 52-week change 322.55%
52-week high 32,966.50
52-week low 32,097.50
50-day moving average 32,241.89
200-day moving average 32,509.51

Share statistics

Avg vol (3-month) 32.11M
Avg vol (10-day) 31.72M
Shares outstanding 5469.65M
Implied shares outstanding 6474.03M
Float 8383.27M
% held by insiders 115.55%
% held by institutions 147.27%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 480
Forward annual dividend yield 43.64%
Trailing annual dividend rate 380.00
Trailing annual dividend yield 33.64%
5-year average dividend yield 42.08
Payout ratio 430.01%
Dividend date 3N/A
Ex-dividend date 427 Sept 2024
Last split factor 25:1
Last split date 329 Mar 2016

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 25.46%
Operating margin (ttm)13.90%

Management effectiveness

Return on assets (ttm)11.16%
Return on equity (ttm)16.56%

Income statement

Revenue (ttm)502.67B
Revenue per share (ttm)1,047.21
Quarterly revenue growth (yoy)4.30%
Gross profit (ttm)N/A
EBITDA 178.43B
Net income avi to common (ttm)127.98B
Diluted EPS (ttm)266.66
Quarterly earnings growth (yoy)2.10%

Balance sheet

Total cash (mrq)204.6B
Total cash per share (mrq)435.64
Total debt (mrq)8.86B
Total debt/equity (mrq)1.11%
Current ratio (mrq)3.99
Book value per share (mrq)1,688.42

Cash flow statement

Operating cash flow (ttm)110.66B
Levered free cash flow (ttm)50.1B